(4-(Bis(4-(tert-butyl)phenyl)amino)phenyl)boronic acid, 97%, 250mg

Ethyl 6-bromo-4-chloroquinazoline-2-carboxylate, 98%, 250mg

1,2:5,6-Bis-o-(1-methylethylidene)-D-mannitol, 95.0%, 500g

2-Bromo-5-cyanopyrazine, 95.0%, 5g

1-Benzothiophene-3-carbaldehyde, 97.0%, 10g

1-(3-Methoxy-4-nitrophenyl)ethanone, 95.0%, 5g

Boîte à spécimens en plastique. Avec de la place pour 25 micropréparations

(R)-Ethyl pyrrolidine-2-carboxylate hydrochloride, 95.0%, 5g

(2-Chlorophenyl)glycine, 98.0%, 1kg

1-Boc-4-(Hydroxymethyl)-4-methylpiperidine, 95.0%, 10g

2-Methyl-5-(trifluoromethoxy)phenylacetic acid, 1g

2-Fluorobenzaldehyde oxime, 95%, 25g

Chloro[[1,3-bis(2,6-diisopropylphenyl)imidazol-2-ylidene](4'-methoxyacetanilide)palladium(II)]>98.0%(T)1g